Oakley Andrew John bought ONCO
March 23, 2025 · Form 4 insider transaction
Oakley Andrew John bought 1,709 shares of Onconetix, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,709
Price
$0.00
Total value
N/A
InsiderOakley Andrew John
Role—
CompanyOnconetix, Inc. (ONCO)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 23, 2025
Filing dateMarch 25, 2025
Shares owned after1,709
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 23, 2025, the Reporting Person was granted 1,709 restricted stock units, which will be settled in shares of common stock, par value $0.00001. The restricted stock units fully vest on August 31, 2025.; Includes unvested RSUs.